Letter to the Editor

Could Sertraline Afford Protection Against Atherosclerosis? A Medical Hypothesis

Authors: Arash Mowla, MD, M R. Namazi, MD

Abstract

To the Editor:


The local oxidation of low density lipoprotein (LDL) within atherosclerotic lesions is widely believed to be of importance in the pathogenesis of atherosclerosis.1 The oxidized LDL promotes adhesion of monocytes to endothelial cells,2 causes an increase in the production of metalloproteinase that would probably destabilize the fibrous caps over advanced lesions,3 and induces apoptosis in cells.4 Macrophages transform into foam cells by incorporating oxidized LDL using several kinds of scavenger receptors.5

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Chisolm GM, Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med 2000;28:1815– 1826.
 
2. Navab M, Berliner JA, Watson AD, et al. The Yin and Yang of oxidation in the development of the fatty streak—a review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler Thromb Vasc Biol 1996;16:831–842.
 
3. Rajavashisth TB, Liao JK, Galis ZS, et al. Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase. J Biol Chem 1999;274:11924– 11929.
 
4. Reid VC, Hardwick SJ, Mitchinson MJ. Fragmentation of DNA in P388D1 macrophages exposed to oxidized low-density lipoprotein. FEBS Lett 1993;332:218–220.
 
5. Steinberg D, Witztum JL. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis. Circulation 2002;105:2107–2111.
 
6. Wen Y, Leake DS. Low density lipoprotein undergoes oxidation within lysosomes in cells. Circ Res 2007;100:1337–1343.
 
7. O’Neil J, Hoppe G, Sayre LM, et al. Inactivation of cathepsin B by oxidized LDL involves complex formation induced by binding of putative reactive sites exposed at low pH to thiols on the enzyme. Free Radic Biol Med 1997;23:215–225.
 
8. Morgan J, Leake DS. Oxidation of low density lipoprotein by iron or copper at acidic pH. J Lipid Res 1995;36:2504–2512.
 
9. Ohkuma S, Poole B. Fluorescence probe measurement of intralysosomal pH in living cells and perturbation of pH by various agents. Proc Natl Acad Sci USA 1978;75:3327–3331.
 
10. Daniel WA, Wójcikowski J, Pałucha A. Intracellular distribution of psychotropic drugs in the grey and white matter of the brain: the role of lysosomal trapping. Br J Pharmacol 2001;134:807–814.